Schedule 13G Filing for Capricor Therapeutics, Inc.

This filing details the beneficial ownership of Capricor Therapeutics, Inc. common stock. Suvretta Capital Management, LLC, along with its advisory clients Averill Master Fund, Ltd. and individual Aaron Cowen, collectively hold a significant stake. Suvretta Capital Management, LLC directly holds 3,417,891 shares, representing 6.6% ownership. Averill Master Fund, Ltd. holds 2,917,420 shares (5.6%), and Aaron Cowen also holds 3,417,891 shares (6.6%). These holdings are primarily for investment purposes and do not appear to be for the purpose of influencing or changing the control of the issuer. The filing includes a joint filing agreement and identifies Suvretta Capital Management, LLC as the control person for Aaron Cowen.